购物车
- 全部删除
- 您的购物车当前为空
NPS2390 是钙敏感受体抑制剂,也是 mGluR1 和 mGluR5 的非竞争性拮抗剂。
为众多的药物研发团队赋能,
让新药发现更简单!
NPS2390 是钙敏感受体抑制剂,也是 mGluR1 和 mGluR5 的非竞争性拮抗剂。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 113 | 现货 | |
5 mg | ¥ 248 | 现货 | |
10 mg | ¥ 398 | 现货 | |
25 mg | ¥ 798 | 现货 | |
50 mg | ¥ 1,180 | 现货 | |
100 mg | ¥ 1,990 | 现货 | |
200 mg | ¥ 2,850 | 现货 |
产品描述 | NPS2390 is a first generation quinoxaline derivative that acts as a noncompetitive antagonist of mGluR1 and mGluR5 (IC50 of 5.2 and 82 nM, respectively) |
靶点活性 | mGluR5:82 nM, mGluR1:5.2nM |
体外活性 | Treatment of NPS2390 was conducive to inhibit the proliferation and reverse phenotypic modulation of PASMCs by regulating autophagy levels. |
分子量 | 307.39 |
分子式 | C19H21N3O |
CAS No. | 226878-01-9 |
Smiles | O=C(NC12CC3CC(CC(C3)C1)C2)c1cnc2ccccc2n1 |
密度 | 1.28 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 3.07 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容